Letter to HELP Committee on PBMs
July 31, 2025 The Honorable Bill Cassidy, Chairman Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 The Honorable Bernie Sanders, Ranking Member Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 Dear Chairman Cassidy and Ranking Member Sanders, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA) […]
PRESS RELEASE New Study Demonstrates Critical Role of American Workers in Building Life-Saving Medicine Infrastructure
June 17, 2025 Research shows the U.S. pharmaceutical industry generated 65 million labor hours and $2.6 billion in wages for skilled union workers who built and maintained advanced pharmaceutical manufacturing facilities across 18 states over the past five years. The Pharmaceutical Industry Labor-Management Association (PILMA) today released groundbreaking research demonstrating the pharmaceutical and biotech industries’ […]
Statement on Executive Order
PILMA Urges Congress to Address IRA’s “Pill Penalty” Following Executive Action April 17, 2025 Bipartisan EPIC Act offers solution to protect patient access, pharmaceutical The Pharmaceutical Industry Labor-Management Association (PILMA) welcomes renewed attention to the harmful impacts of the Inflation Reduction Act’s so-called “pill penalty,” highlighted in the April 15 Presidential Executive Order. The pill […]
The Feds must stop going easy on foreign patent thieves who hurt Pennsylvania | Opinion
Ron KlinkSpecial to the USA TODAY NetworkApril 4, 2025 Key Points In the past few months, researchers at the University of Pittsburgh have received more than a dozen patents, including for an experimental probiotic weight-loss therapy, a more durable and flexible solar cell and a new method of detecting and treating pancreatic cancer.But Pitt doesn’t […]
PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act
February 25, 2025 PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act Bipartisan legislation would correct the “pill penalty” to safeguard union jobs and ensure continued innovation in small-molecule therapies The Pharmaceutical Industry Labor-Management Association (PILMA) applauds the introduction of the Ensuring Pathways to Innovative Cures (EPIC) Act (H.R. 1492), a bipartisan […]
President McManus Letter on PBMs to Congress
November 21, 2024 Dear Speaker Johnson, Leader Jeffries, Leader Schumer, and Leader McConnell, As Congress returns to Washington for the remaining weeks of the legislative session, lawmakers have a critical opportunity to deliver meaningful reforms that will provide relief to millions of hardworking families struggling with high prescription drug costs. As a labor union representing […]
United Association President McManus Letter to HELP Committee
September 25, 2024 To:The Office of Senator Bernie Sanders, ChairU.S. Senate Committee on Health, Education, Labor, and Pensions332 Dirksen Senate Office Bldg. Washington, D.C., 20510 The Office of Senator Bill Cassidy, Ranking MemberU.S. Senate Committee on Health, Education, Labor, and Pensions455 Dirksen Senate Office Bldg.Washington, D.C., 20510 cc: Members of the Senate HELP Committee Dear […]
STATEMENT CONCERNING CMS’ Announcement of 10 Drugs Selected for 2026 Government Price Controls
August 13, 2024Today, the Centers for Medicare and Medicaid Services (CMS) released the Maximum Fair Prices (MFPs) for 10 selected medicines to go into effect in 2026. PILMA reiterates our opposition to MFPs, which are simply government price controls on medicines in Medicare under the guise of negotiation. PILMA has long opposed price controls in […]
STATEMENT Supporting the House Oversight Committee Hearings on PBM Transparency and Accountability
July 23, 2024 The labor and industry partners of the Pharmaceutical Industry Labor- Management Association (PILMA) applaud the House Oversight Committee’s investigation into the role of PBMs in prescription drug markets. PILMA has a long history of supporting increased transparency and accountability in the prescription drug supply chain and has repeatedly called on lawmakers to […]
THE MIDDLEMEN: The Opaque Industry Secretly Inflating Prices for Prescription DrugsPharmacy benefit managers are driving up drug costs for millions of people, employers and the government.
By Rebecca Robbins and Reed Abelson This is the first article in a series about how pharmacy benefit managers prioritize their interests, often at the expense of patients, employers and taxpayers. Americans are paying too much for prescription drugs. It is a common, longstanding complaint. And the culprits seem obvious: Drug companies. Insurers. A dysfunctional federal government. But […]